Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya (APS)

6 april 2017 uppdaterad av: Carey Farquhar, University of Washington

The main purpose of this implementation science study is to find out if providing aPS at 18 different Ministry of Health (MOH) VCT clinics in Kenya works and is cost-effective. This would enable co-investigators in the Kenyan MOH to justify funding to scale-up these services.

The primary aim of the study is to find out whether providing aPS to sexual partners of newly tested HIV-infected individuals can result in more sexual partners getting counseled and HIV tested and linked to HIV care programs for initiation of ART if appropriate. The investigators hypothesize that aPS will increase rates of case-finding, linkages to care, and ART initiation and will not result in social harm.

The second aim is whether aPS is cost-effective in the Kenyan setting. The investigators will estimate how much it costs (when compared to standard methods) to identify and link HIV-infected persons into care. The investigators will also determine how successful aPS is at preventing future HIV transmission events and other outcomes associated with untreated HIV infection. The investigators hypothesize that HIV prevalence among partners in the immediate aPS arm will be high enough to make this approach cost-effective from the payer and societal perspective.

Finally, with the Kenya MOH, the investigators want to establish a nationwide monitoring system to evaluate why Kenyans are testing for HIV. In the future, when aPS is rolled out nationally, this will help Kenyan public health officials define the contribution of aPS to HIV case-finding. The investigators hypothesize that the proportion of newly tested HIV-infected individuals who report testing because of known exposure to a person with HIV will represent a significant proportion of new cases and the investigators will be able to identify places in Kenya where aPS will have the greatest impact on HIV treatment and prevention.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

Diagnosing HIV soon after infection can benefit individuals and also has important public health benefits. It has been shown that starting antiretroviral therapy (ART) before HIV has progressed results in a better response to treatment and gives the person a better chance of long-term survival with HIV. Treating HIV can also reduce the risk that someone will transmit HIV to his or her sexual partners. The first step in achieving these individual and population level benefits is testing people for HIV. Unfortunately, in many parts of the world, including Kenya where we plan to conduct this study, many people are not tested regularly and do not know that they are infected. This study involves providing a public health service, notification of an exposure to a communicable disease and HIV testing, to sexual partners of those who test HIV-positive at voluntary counseling and testing (VCT) clinics in Kenya. Sexual partners are identified voluntarily by the person who tests at the VCT. A public health provider then goes to the home of the sexual partners to offer them HIV counseling and testing. This process is called provision of assisted partner services (aPS).

We propose a cluster randomized clinical trial which will be conducted in collaboration with the Kenya Ministry of Health (MOH) at 18 rural and urban voluntary counseling and testing (VCT) facilities across Kenya. Proposed activities will assess the effectiveness and cost-effectiveness of providing aPS, improve capacity for program implementation in Kenya, and lay the foundation for evaluating the program's impact at the national level.

Studietyp

Interventionell

Inskrivning (Faktisk)

2424

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Kiambu, Kenya
        • Karuri VCT
      • Kiambu, Kenya
        • Kiambu Hospital VCT
      • Kiambu, Kenya
        • Kirwara VCT
      • Kisumu, Kenya
        • Chulaimbo Health Centre
      • Kisumu, Kenya
        • Joo Trh Vct
      • Kisumu, Kenya
        • Kisumu East District Hospital
      • Kisumu, Kenya
        • Kombewa VCT
      • Maseno, Kenya
        • Maseno Mission
      • Nairobi, Kenya
        • Baba Dogo VCT
      • Nairobi, Kenya
        • Casino VCT
      • Nairobi, Kenya
        • Huruma Lions
      • Nairobi, Kenya
        • Kariobangi VCT
      • Nairobi, Kenya
        • Kenyatta National Hospital (KNH) VCT
      • Nairobi, Kenya
        • Mama Lucy Kibaki VCT
      • Nairobi, Kenya
        • Mbagathi VCT
      • Nairobi, Kenya
        • Pumwani VCT
      • Siaya, Kenya
        • Abidha Health Centre
      • Siaya, Kenya
        • Ongielo Health Centre

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Written informed consent is required of all participants. All participants must be 18 years or older.
  • Index case participants must be HIV-seropositive, and willing and able to provide locator information for sexual partners in the past three years.

Exclusion Criteria:

  • Index cases will be excluded from participation if they are pregnant, or have reported intimate partner violence during the last month. There is no exclusion criteria for partner participants.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Delayed aPS
Experimentell: Immediate aPS
Assisted-partner notification services (aPS) is a public health service which notifies the partners of those who test positive for a communicable disease of their exposure.
Andra namn:
  • Partner notification services
  • Assisted partner services

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Number of partners testing for HIV
Tidsram: 6 week period following index case enrollment
The number of partners of an index participant that were tested for HIV (offset will be the number of partners with locator information provided by the index participant).
6 week period following index case enrollment
Newly tested HIV-infected partners
Tidsram: 6 week period following index case enrollment
The number of partners of an index participant identified as HIV-infected (offset will be the number of partners of that index participant who were HIV tested).
6 week period following index case enrollment
Number of partners linking to HIV care
Tidsram: 6 week period following index case enrollment
The number of partners of an index participant who were linked to HIV care (offset will be the number of partners of an index participant identified as HIV-infected and analysis will be limited to index participants with at least one HIV-infected partner.)
6 week period following index case enrollment

Sekundära resultatmått

Resultatmått
Tidsram
Incremental cost-effectiveness from payer and societal perspectives
Tidsram: 6 week period following index case enrollment
6 week period following index case enrollment
Proportion of individuals with newly diagnosed HIV infection who report testing because of known exposure to a person with HIV
Tidsram: 6 week period after index case enrollment
6 week period after index case enrollment
Costs of identifying >1 partner per index case
Tidsram: 6 week period after index case enrollment
6 week period after index case enrollment

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Carey Farquhar, MD, MPH, University of Washington
  • Studiestol: Peter Cherutich, MBChB, MPH, Kenya Ministry of Health
  • Studiestol: Matthew Golden, MD, MPH, University of Washington

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 juni 2012

Primärt slutförande (Faktisk)

1 augusti 2015

Avslutad studie (Faktisk)

1 augusti 2015

Studieregistreringsdatum

Först inskickad

7 juni 2012

Först inskickad som uppfyllde QC-kriterierna

8 juni 2012

Första postat (Uppskatta)

11 juni 2012

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

10 april 2017

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

6 april 2017

Senast verifierad

1 april 2017

Mer information

Termer relaterade till denna studie

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera